Mandatory information for the Primary and Consumer Care Book

As of February 2026

Aqualibra® 80 mg/90 mg/180 mg film‑coated tablets.
For urinary flushing therapy in bacterial and inflammatory diseases of the urinary tract.
As flushing therapy for the prevention and treatment of urinary stones and renal gravel.
For adolescents aged 12 years and over and adults.
If there is blood in the urine, fever, or if symptoms persist for more than 5 days, a doctor must be consulted.
Contains lactose and glucose.
For information on risks and side effects, read the package leaflet and ask your doctor, pharmacist or healthcare professional.
08/2022


Biocarn®.
Active ingredient: 1 g levocarnitine / 3.3 ml syrup.
Therapeutic indications:
– For substitution therapy in primary and secondary systemic carnitine deficiency;
– As a therapeutic trial in special forms of muscular dystrophy (muscle wasting) with lipid accumulation (fat accumulation) based on a primary muscular carnitine deficiency;
– As an adjunct to the treatment of progressive Duchenne muscular dystrophy, provided that functional skeletal muscles are still present;
– For replacement of dialysis‑related levocarnitine losses during chronic haemodialysis.
For information on risks and side effects, read the package leaflet and ask your doctor, pharmacist or healthcare professional.
Date of information: 02/2022.
MEDICE Arzneimittel, 58638 Iserlohn.


Cystinol akut® dragées,
Active ingredient: bearberry leaf dry extract.
Therapeutic indications: inflammatory diseases of the urinary tract.
Warning: contains lactose.
Please read the package leaflet.
For information on risks and side effects, read the package leaflet and ask your doctor, pharmacist or healthcare professional.
Pharmacy‑only medicine.
Date of information: 11/2023.
Schaper & Brümmer GmbH & Co. KG, Bahnhofstr. 35, 38259 Salzgitter.


Doregrippin® 500 mg / 10 mg film‑coated tablets.
Therapeutic indications: for the short‑term treatment of symptoms of colds and flu‑like infections accompanied by fever, headache, limb pain and runny nose.
For children aged 11 years and over and adults.
Do not use for longer than stated in the package leaflet without medical advice.
For information on risks and side effects, read the package leaflet and ask your doctor, pharmacist or healthcare professional.
Date of information: 03/2023.
MEDICE Arzneimittel, 58638 Iserlohn.


Dorithricin® Classic lozenges.
Therapeutic indications: for the symptomatic treatment of infections of the mouth and throat accompanied by sore throat and difficulty swallowing.
Contains sorbitol and peppermint oil.
For information on risks and side effects, read the package leaflet and ask your doctor, pharmacist or healthcare professional.
Date of information: 04/2022.
MEDICE Arzneimittel, 58638 Iserlohn.


Dorithricin® Classic lozenges / Dorithricin® Wild Berry lozenges.
Therapeutic indications: for the symptomatic treatment of infections of the mouth and throat accompanied by sore throat and difficulty swallowing.
Dorithricin® Classic contains sorbitol and peppermint oil.
Dorithricin® Wild Berry contains sorbitol.
For information on risks and side effects, read the package leaflet and ask your doctor, pharmacist or healthcare professional.
Date of information: 04/2022 and 01/2023 respectively.
MEDICE Arzneimittel, 58638 Iserlohn.


Dorithricin® Wild Berry lozenges.
Therapeutic indication: for the symptomatic treatment of infections of the mouth and throat accompanied by sore throat and difficulty swallowing.
Contains sorbitol.
For information on risks and side effects, read the package leaflet and ask your doctor, pharmacist or healthcare professional.
Date of information: 01/2023.
MEDICE Arzneimittel, 58638 Iserlohn.


Dorithricin® Classic lozenges / Dorithricin® Wild Berry lozenges.
Therapeutic indications: for the symptomatic treatment of infections of the mouth and throat accompanied by sore throat and difficulty swallowing.
Dorithricin® Classic contains sorbitol and peppermint oil.
Dorithricin® Wild Berry contains sorbitol.
For information on risks and side effects, read the package leaflet and ask your doctor, pharmacist or healthcare professional.
Date of information: 04/2022 and 01/2023 respectively.
MEDICE Arzneimittel, 58638 Iserlohn.


Esberitox® Compact.
Therapeutic indication: supportive treatment of viral cold diseases.
For information on risks and side effects, read the package leaflet and ask your doctor, pharmacist or healthcare professional.
Pharmacy‑only medicine.
Date of information: 11/2023.
Schaper & Brümmer GmbH & Co. KG, Bahnhofstr. 35, 38259 Salzgitter.


Esberitox®.
Therapeutic indication: supportive treatment of viral cold diseases.
For information on risks and side effects, read the package leaflet and ask your doctor, pharmacist or healthcare professional.
Pharmacy‑only medicine.
Date of information: 01/2024.
Schaper & Brümmer GmbH & Co. KG, Bahnhofstr. 35, 38259 Salzgitter.


Exoderil cream 10 mg.
Therapeutic indications: fungal infections of the skin (dermatomycoses) caused by dermatophytes, yeasts and moulds as well as mixed infections with bacteria.
Warnings: contains stearyl alcohol, cetyl alcohol and benzyl alcohol.
Avoid contact with eyes.
For information on risks and side effects, read the package leaflet and ask your doctor, pharmacist or healthcare professional.
08/2021


Exoderil gel 10 mg.
Therapeutic indications: fungal infections of the skin (dermatomycoses) caused by dermatophytes, yeasts and moulds as well as mixed infections with bacteria.
In fungal infections of the nails (onychomycoses), a therapeutic trial is indicated.
Warnings: contains propylene glycol.
Avoid contact with eyes.
Do not apply to mucous membranes or open wounds.
For information on risks and side effects, read the package leaflet and ask your doctor, pharmacist or healthcare professional.
08/2021


Femicur® N capsules.
Active ingredient: chaste tree fruit dry extract.
Therapeutic indications: disorders of the menstrual cycle rhythm (cycle rhythm abnormalities), recurring monthly symptoms prior to menstruation (premenstrual symptoms), sensation of tension and swelling in the breasts (mastodynia).
Warning: contains glucose and lactose; please read the package leaflet.
For information on risks and side effects, read the package leaflet and ask your doctor, pharmacist or healthcare professional.
Pharmacy‑only medicine.
Date of information: 11/2023.
Schaper & Brümmer GmbH & Co. KG, Bahnhofstr. 35, 38259 Salzgitter.

 

Mediolax® Medice, 10 mg gastro‑resistant tablets.
Active ingredient: bisacodyl.
Therapeutic indications: for short‑term use in constipation; in conditions requiring facilitated defecation.
For use in children aged 10 years and over as well as adults.
For information on risks and side effects, read the package leaflet and ask your doctor, pharmacist or healthcare professional.
Date of information: 07/2016.
MEDICE Arzneimittel, 58638 Iserlohn.


Meditonsin® Extract Herbal Cold Tablets.
Therapeutic indication: supportive treatment of viral cold diseases.
For information on risks and side effects, read the package leaflet and ask your doctor, pharmacist or healthcare professional.
Pharmacy‑only medicine.
Date of information: 06/2025.
Schaper & Brümmer GmbH & Co. KG, Bahnhofstr. 35, 38259 Salzgitter.


Meditonsin® Extract Herbal Cold Tablets / Meditonsin® Extract Junior Herbal Cold Tablets.
Therapeutic indication: supportive treatment of viral cold diseases.
For information on risks and side effects, read the package leaflet and ask your doctor, pharmacist or healthcare professional.
Pharmacy‑only medicine.
Date of information: 06/2025.
Schaper & Brümmer GmbH & Co. KG, Bahnhofstr. 35, 38259 Salzgitter.


Meditonsin® Extract Junior Herbal Cold Tablets.
Therapeutic indication: supportive treatment of viral cold diseases.
For information on risks and side effects, read the package leaflet and ask your doctor, pharmacist or healthcare professional.
Pharmacy‑only medicine.
Date of information: 06/2025.
Schaper & Brümmer GmbH & Co. KG, Bahnhofstr. 35, 38259 Salzgitter.


Meditonsin® Extract Herbal Cold Tablets / Meditonsin® Extract Junior Herbal Cold Tablets.
Therapeutic indication: supportive treatment of viral cold diseases.
For information on risks and side effects, read the package leaflet and ask your doctor, pharmacist or healthcare professional.
Pharmacy‑only medicine.
Date of information: 06/2025.
Schaper & Brümmer GmbH & Co. KG, Bahnhofstr. 35, 38259 Salzgitter.


Meditonsin® Drops / Meditonsin® Globules.
The therapeutic indications are derived from the homeopathic drug pictures. These include: acute inflammations of the throat, nose and pharyngeal area.
Meditonsin® Drops contain 6% alcohol by volume.
Meditonsin® Globules contain sucrose.
For information on risks and side effects, read the package leaflet and ask your doctor, pharmacist or healthcare professional.
Date of information: 01/2022 and 02/2022 respectively.
MEDICE Arzneimittel, 58638 Iserlohn.


Meditonsin® Globules.
The therapeutic indications are derived from the homeopathic drug pictures. These include: acute inflammations of the throat, nose and pharyngeal area.
Contains sucrose.
For information on risks and side effects, read the package leaflet and ask your doctor, pharmacist or healthcare professional.
Date of information: 02/2022.
MEDICE Arzneimittel, 58638 Iserlohn.


Meditonsin® Drops.
The therapeutic indications are derived from the homeopathic drug pictures. These include: acute inflammations of the throat, nose and pharyngeal area.
Contains 6% alcohol by volume.
For information on risks and side effects, read the package leaflet and ask your doctor, pharmacist or healthcare professional.
Date of information: 01/2022.
MEDICE Arzneimittel, 58638 Iserlohn.


Meditonsin® Drops / Meditonsin® Globules.
The therapeutic indications are derived from the homeopathic drug pictures. These include: acute inflammations of the throat, nose and pharyngeal area.
Meditonsin® Drops contain 6% alcohol by volume.
Meditonsin® Globules contain sucrose.
For information on risks and side effects, read the package leaflet and ask your doctor, pharmacist or healthcare professional.
Date of information: 01/2022 and 02/2022 respectively.
MEDICE Arzneimittel, 58638 Iserlohn.


Medivitan® iV pre‑filled syringe, Medivitan® iV ampoules.
Combined deficiency of vitamin B6, vitamin B12 and folic acid in adults which cannot be corrected by dietary measures.
Contains sodium.
For information on risks and side effects, read the package leaflet and ask your doctor, pharmacist or healthcare professional.
Date of information: 08/2021.
MEDICE Arzneimittel, 58638 Iserlohn.


Medyn® forte capsules.
Confirmed combined deficiency of vitamins B6, B12 and folic acid which cannot be corrected by dietary measures.
For information on risks and side effects, read the package leaflet and ask your doctor, pharmacist or healthcare professional.
Date of information: 05/2018.
MEDICE Arzneimittel, 58638 Iserlohn.


Melabon® K 250 mg / 250 mg / 50 mg tablets.
Therapeutic indication: Melabon® K is used for mild to moderate pain.
For use in adults and in children aged 12 years and over when other measures are ineffective.
Warning: do not use for longer than stated in the package leaflet without medical advice in cases of pain or fever.
For information on risks and side effects, read the package leaflet and ask your doctor, pharmacist or healthcare professional.
Date of information: 07/2022.
MEDICE Arzneimittel, 58638 Iserlohn.


Perenterol® forte 250 mg capsules.
Active ingredient: dried yeast from Saccharomyces cerevisiae HANSEN CBS 5926 (synonym: Saccharomyces boulardii).
Therapeutic indications: for the treatment of symptoms of acute diarrhoeal diseases; for the prevention and treatment of symptoms of traveller’s diarrhoea as well as diarrhoea associated with tube feeding.
For adjunctive treatment in long‑standing forms of acne.
For adults and children aged 2 years and over.
Warning: contains lactose.
For information on risks and side effects, read the package leaflet and ask your doctor, pharmacist or healthcare professional.
Date of information: 08/2024.
MEDICE Arzneimittel, 58638 Iserlohn.


Perenterol® Junior 250 mg powder.
Active ingredient: dried yeast from Saccharomyces cerevisiae HANSEN CBS 5926 (synonym: Saccharomyces boulardii).
Therapeutic indications: for the treatment of symptoms of acute diarrhoeal diseases, including traveller’s diarrhoea and diarrhoea associated with tube feeding.
For the prevention of traveller’s diarrhoea.
For use in acute diarrhoea in children and adults aged 2 years and over, and in infants from 6 months after consultation with a doctor.
For the prevention of traveller’s diarrhoea in adolescents and adults aged 12 years and over.
Warning: contains lactose, fructose and sorbitol.
For information on risks and side effects, read the package leaflet and ask your doctor, pharmacist or healthcare professional.
Date of information: 08/2024.
MEDICE Arzneimittel, 58638 Iserlohn.


Remifemin®.
Active ingredient: dry extract from black cohosh rhizome.
Therapeutic indications: Remifemin® is used to alleviate psychological and neurovegetative symptoms associated with menopause, such as hot flushes, sweating and sleep disturbances.
Warning: contains lactose.
Please read the package leaflet.
For information on risks and side effects, read the package leaflet and ask your doctor, pharmacist or healthcare professional.
Pharmacy‑only medicine.
Date of information: 11/2023.
Schaper & Brümmer GmbH & Co. KG, Bahnhofstr. 35, 38259 Salzgitter.


Remifemin® mono.
Active ingredient: dry extract from black cohosh rhizome.
Therapeutic indications: menopausal symptoms such as hot flushes and excessive sweating.
Warning: contains lactose.
Please read the package leaflet.
For information on risks and side effects, read the package leaflet and ask your doctor, pharmacist or healthcare professional.
Pharmacy‑only medicine.
Date of information: 11/2023.
Schaper & Brümmer GmbH & Co. KG, Bahnhofstr. 35, 38259 Salzgitter.


Remifemin® plus St John’s wort.
Therapeutic indications: for the relief of hot flushes and excessive sweating during menopause when these symptoms are accompanied by additional psychological menopausal symptoms such as low mood, nervousness and irritability.
Warning: 1 film‑coated tablet contains 163 mg lactose and 0.5 mg (3‑sn‑phosphatidyl)choline (soybean).
Please read the package leaflet.
For information on risks and side effects, read the package leaflet and ask your doctor, pharmacist or healthcare professional.
Pharmacy‑only medicine.
Date of information: 11/2023.
Schaper & Brümmer GmbH & Co. KG, Bahnhofstr. 35, 38259 Salzgitter.


Remisens®.
Active ingredient: 225 mg damiana leaf dry extract.
Therapeutic indications: traditional herbal medicinal product for use as an aphrodisiac in cases of reduced sexual desire.
Remisens® is a traditional medicinal product registered for this indication exclusively on the basis of long‑standing use.
For information on risks and side effects, read the package leaflet and ask your doctor, pharmacist or healthcare professional.
Date of information: 11/2023.
Schaper & Brümmer GmbH & Co. KG, Bahnhofstr. 35, 38259 Salzgitter.


Sedacur® forte calming dragées.
Therapeutic indication: states of restlessness and sleep‑onset disorders caused by nervousness.
Warning: contains, among other ingredients, glucose and sucrose (sugar).
If symptoms persist for more than 2 weeks or worsen, a doctor must be consulted in any case.
Please read the package leaflet.
For information on risks and side effects, read the package leaflet and ask your doctor, pharmacist or healthcare professional.
Date of information: 11/2023.
Schaper & Brümmer GmbH & Co. KG, Bahnhofstr. 35, 38259 Salzgitter.


Soventol® Gel 20 mg/g gel.
Therapeutic indications: for the relief of mild to moderately severe reactions to insect bites (e.g. mosquito bites) with itching.
For information on risks and side effects, read the package leaflet and ask your doctor, pharmacist or healthcare professional.
Date of information: 07/2022.
MEDICE Arzneimittel, 58638 Iserlohn.


Soventol® HydroCort 0.5% cream, 5 mg/g.
Therapeutic indications: for the treatment of all skin diseases that respond to treatment with corticosteroids, such as inflammatory, allergic or pruritic dermatoses (skin inflammations, eczema).
Warnings: contains, among other ingredients, sorbic acid, potassium sorbate, cetylstearyl alcohol, sodium dodecyl sulfate and propylene glycol.
For information on risks and side effects, read the package leaflet and ask your doctor, pharmacist or healthcare professional.
Date of information: 07/2022.
MEDICE Arzneimittel, 58638 Iserlohn.


Soventol® Hydrocortisone acetate 0.25% cream, 2.5 mg/g.
Therapeutic indications: for the treatment of inflammatory and allergic dermatoses (skin inflammations and eczema) with mild to moderate symptom severity that respond to topical treatment with weakly effective corticosteroids.
For information on risks and side effects, read the package leaflet and ask your doctor, pharmacist or healthcare professional.
Date of information: 07/2022.
MEDICE Arzneimittel, 58638 Iserlohn.


Soventol® Hydrocortisone acetate 0.5% cream, 5 mg/g.
Therapeutic indications: for the treatment of moderately pronounced reddened, inflammatory or allergic skin diseases in which weakly effective, low‑concentration corticosteroids are indicated.
Warning: do not use in children under 6 years of age without a doctor’s prescription.
For information on risks and side effects, read the package leaflet and ask your doctor, pharmacist or healthcare professional.
Date of information: 07/2022.
MEDICE Arzneimittel, 58638 Iserlohn.


Soventol® PROTECT.
Use biocidal products with care. Always read the label and product information before use.
MEDICE Arzneimittel, 58638 Iserlohn.


Soventol® HydroCort 0.5% spray, 5 mg/g solution.
Therapeutic indications: for the relief of non‑infected mild inflammatory, allergic or pruritic skin diseases that respond to symptomatic treatment with weakly effective glucocorticosteroids.
Soventol® HydroCort 0.5% spray is particularly suitable for use on normal or oily skin.
Warnings: contains propylene glycol and ethanol.
For information on risks and side effects, read the package leaflet and ask your doctor, pharmacist or healthcare professional.
Date of information: 08/2022.
MEDICE Arzneimittel, 58638 Iserlohn.


Tannacomp® 500 mg / 50 mg film‑coated tablets.
Active ingredients: tannin albuminate, ethacridine lactate monohydrate.
Therapeutic indications: treatment of acute non‑specific diarrhoea; prophylaxis and treatment of traveller’s diarrhoea.
For adults, adolescents and children aged 5 years and over.
For information on risks and side effects, read the package leaflet and ask your doctor, pharmacist or healthcare professional.
Date of information: 09/2022.
MEDICE Arzneimittel, 58638 Iserlohn.


Tannalbin® 500 mg tablets.
Active ingredient: tannin‑protein complex.
Therapeutic indications: supportive treatment of acute non‑specific diarrhoeal diseases, such as summer diarrhoea and traveller’s diarrhoea.
For adults and children aged 5 years and over.
For information on risks and side effects, ask your doctor, pharmacist or healthcare professional.
Date of information: 09/2022.
MEDICE Arzneimittel, 58638 Iserlohn.